Clearpoint Neuro Inc (CLPT)

R&D Expense Growth

2.43%

Quarterly · Period ending:

CLPT logo

CLPT R&D Expense Growth

Latest reported2.43%
CLPT Quarterly R&D Growth (QoQ) (0.00% → 2.43%)
High-resolution chart · PNG

CLPT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Clearpoint Neuro Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
2.4326%
39.6973%
-6.2283%
-9.8459%
13.3175%
1.4106%
0.5128%
6.25%
18.8571%
-1.0181%
9.1807%
-32.6214%
19.2524%
-16.5839%
36.5486%
10.0788%
-16.8907%
6.1083%
5.1134%
22.5153%
35.8285%
-14.3619%
59.6783%
40.7635%
-0.7335%
-6.8395%
15.2483%
9.1828%
19.3764%
21.452%
-22.0251%
-7.2251%
21.7785%
-6.1547%
-1.2816%
-45.6083%
94.4063%
5.283%
-23.3775%
-7.8155%
14.1131%
25.7521%
8.8134%
12.4959%
-19.0671%
-25.4613%
-18.9685%
-2.789%
9.8826%
19.4762%
-5.6481%
-2.226%
-3.8416%
4.9239%
28.1902%
18.0115%
-29.5282%
-38.3035%
22.8518%
-14.0474%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.